Data protection Impressum

Medtech

From left to right: Christoph Ammann, Canton of Bern - Dr. med. h.c. Uwe E. Jocham, Insel Gruppe - Prof. Dr. Christian Leumann, University of Bern - Dr. Alexandre Pauchard, CSEM, Jens Krauss, CSEM.

Bern’s journey to becoming a world-class medtech hub by 2030

9 November 2023

This strategic partnership will allow Fapon to research, develop, make, and sell PSP materials and test solutions using the chemiluminescence immunoassay (CLIA) in the Chinese market.

Abionic and Lascco partner with Fapon for sepsis diagnosis in China

2 November 2023

Thomas Ingold, CEO and Founder of DroneControl Sàrl.

Four innovative Geneva start-ups receive FIF support

31 October 2023

Marco Scicolone (to the left) and Alexander Fink (to the right) are looking forward to working together.

Regulatory compliance expert Metecon establishes its Swiss subsidiary in Bern

30 October 2023

NASA will use Compremium's CPMX1 System for extended space voyages to the Moon and Mars, aiming to safeguard astronaut well-being throughout extended zero-gravity journeys.

Compremium’s breakthrough medical device embarks on a NASA voyage

25 October 2023

On 19 September 2023, Mecaplast Swiss, a 50-year veteran in plastic injection with a medtech specialization, welcomed 50 Swiss Health Valley members on the occasion of BioAlps’ 4à6 event.

Mecaplast Swiss, 50 years of innovation in the canton of Fribourg

24 October 2023

From left to right: Prof. Han (Professor of Yonsei Cancer Center), Dr. Chun (CSO of Oncosoft), Prof. Dong Wook Kim (Clinical Professor, Yonsei Cancer Center), Laura Acosta (Swiss Embassy Representative), Prof. Ik Jae Lee (Director of Heavy Ion Therapy, Yonsei Cancer Center), Dr. Christina Vallgren (CEO of Terapet), Herve Duffour (Sales and Marketing director of Terapet), Prof. Jin Sung Kim (Chief Medical Physicist of Yonsei Cancer Center & CEO of Oncosoft).

Terapet enters partnership with Korean entities for its breakthrough cancer therapy device

18 October 2023

Mimix’s objective, as outlined in its strategic vision, is to introduce this wound care product to the US market by the second half of 2024.

Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment

17 October 2023

With Atinary’s SDLabs, individuals or organizations can effortlessly incorporate ML into their existing workflows, with or without the utilization of robots, or in a simulation environment, to enhance and expedite R&D operations immediately.

Atinary Technologies raises USD 5 million to accelerate material and molecular innovation

3 October 2023

ONWARD’s ARC therapy helps enable people with spinal cord injury to move again.

ONWARD advances into the US Federal Health arena by helping disabled veterans

20 September 2023

1 … 8 9 10 11 12 13 14 15 16 … 19